The authors report a positive correlation between TGF-β1 and SALL4 in GC tissues and provide evidence that TGF-β1 acts as a downstream effector of SALL4 in GC progression, as its knockdown reverses SALL4-mediated promotion of GC migration, invasion, and metastasis [89]. The gene discussed is SALL4; the disease is gastric cancer.